Evidence map›Paper›PMID 38257401›Full record

ArticleMolecules (Basel, Switzerland)2024

Synthesis and PET Imaging Biodistribution Studies of Radiolabeled Iododiflunisal, a Transthyretin Tetramer Stabilizer, Candidate Drug for Alzheimer's Disease.

Sameer M Joshi, Thomas C Wilson, Zibo Li, Sean Preshlock, Vanessa Gómez-Vallejo, Véronique Gouverneur, Jordi Llop, Gemma Arsequell

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Sameer M JoshiCIC BiomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, Parque Tecnológico de San Sebastián, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0001-8989-5661
Thomas C WilsonChemistry Research Laboratory, Oxford University, Oxford OX1 3TA, UK.
Zibo LiDepartment of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-1063-0298
Sean PreshlockChemistry Research Laboratory, Oxford University, Oxford OX1 3TA, UK.
Vanessa Gómez-VallejoCIC BiomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, Parque Tecnológico de San Sebastián, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0003-3995-9596
Véronique GouverneurChemistry Research Laboratory, Oxford University, Oxford OX1 3TA, UK.ORCID 0000-0001-8638-5308
Jordi LlopCIC BiomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, Parque Tecnológico de San Sebastián, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0002-0821-9838
Gemma ArsequellInstitut de Química Avançada de Catalunya (IQAC), Spanish National Research Council (CSIC), 08034 Barcelona, Spain.ORCID 0000-0002-7009-3738
University of Oxford · GBCIC biomaGUNE · ESUniversity of North Carolina at Chapel Hill · USConsejo Superior de Investigaciones Científicas · ES

Funding

European Commission FP7- PEOPLE-2012-ITN; ID: 316882Ministerio de Ciencia e Innovación PID2020-117656RB-I00
6 · The paper itself

Abstract

The small-molecule iododiflunisal (IDIF) is a transthyretin (TTR) tetramer stabilizer and acts as a chaperone of the TTR-Amyloid beta interaction. Oral administration of IDIF improves Alzheimer's Disease (AD)-like pathology in mice, although the mechanism of action and pharmacokinetics remain unknown. Radiolabeling IDIF with positron or gamma emitters may aid in the in vivo evaluation of IDIF using non-invasive nuclear imaging techniques. In this work, we report an isotopic exchange reaction to obtain IDIF radiolabeled with

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsDiflunisalExcipientsHumansMicePharmaceutical PreparationsPrealbuminTissue DistributionAmyloid beta-PeptidesDiflunisalExcipientsiododiflunisalPharmaceutical PreparationsPrealbumin18Famyloid betain vivo imagingiododiflunisalpositron emission tomography (PET)small-molecule chaperonetransthyretin tetramer stabilizer

Identifiers

PMID38257401
PMCPMC10818730
OpenAlexW4390972520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.